Khaled Elrefae – General Manager, Ipsen MEA
General manager of MEA, Khaled Elrefae, explains how Ipsen has strengthened its footprint in the region over the past two years – starting in the UAE and expanding into Saudi…
MINAPHARM ranks among the leading pharmaceutical companies in Egypt and the Middle East. The company maintains one of the broadest quality-products portfolio within the industry. Their longstanding expertise covers a broad spectrum of medicines, ranging from small molecules to extremely complex bioengineered proteins. Minapharm is leading a transition towards high-value biologicals in developing markets, while expanding a robust small-molecule setup in a business model that represents a far departure from existing regional models. In addition to production of life-saving and life-enhancing medicines, MINAPHARM is adopting an international operation platform for biotechnology and cellular engineering. Novel scientific solutions and technologies contribute to the development of products that were unimaginable a decade ago. Scientific excellence and expertise in cellular and bioprocess engineering enable the companies mission to provide not only developed markets, but also emerging markets with significant economic molecules, thus striking the next frontier. MINAPHARM is constantly demonstrating its ability to achieve the balance between Innovation and Affordability, hence, facing the most complex challenges of unmet medical needs in emerging countries.
Contact
El-Bardissi St., 2T Takseem Asmaa Fahmy St., Heliopolis, Cairo – Egypt.
(+202) 2414-3170/1/2/3/4/5
(+202) 2414-3179
General manager of MEA, Khaled Elrefae, explains how Ipsen has strengthened its footprint in the region over the past two years – starting in the UAE and expanding into Saudi…
Building on a stellar career in pharma and medtech both in Egypt and internationally, Ahmed Ezz El-Din now serves as CEO of Cleopatra Hospitals Group, Egypt’s largest private hospital provider.…
While evidence and recognition are growing that gender-balanced and diverse management teams at all levels of hierarchies produce positive business outcomes, the MENA region still has a long road to…
Bristol Myers Squibb’s Oscar Delgado outlines the firm’s successes in bringing innovative medicines to the Middle East and Africa in recent years, how its strategy plays out in an economically…
While universal health insurance is the talk of the town in Egypt today, private healthcare groups – serving up to 40 percent of the population in both the insurance and…
Based in Egypt, Medtronic Africa’s regional vice president, Eman Ali, speaks about the challenges of building a strategic roadmap and local capabilities for the entire African continent from the ground…
First founded in 2019 as a new regulatory body independent from Egypt’s Ministry of Health, the Egyptian Drug Authority (EDA) has made significant progress over the last three years. Now…
Neeraj Mishra of Alameda Healthcare, the largest private healthcare organisation in Egypt, outlines the organisation’s strategy for Egypt and Africa, how – as a provider of private hospitals – it…
The COVID-19 pandemic and the subsequent struggle to obtain vaccines shone a harsh light on Africa’s reliance on pharma exports. As a McKinsey study notes, there were only around 375…
AbbVie’s GM for Egypt & Levant, Ali Sleiman, explains the factors behind the stellar growth that has made the cluster one of the company’s fastest-growing global markets in 2021. He…
With over 100 years of pharmaceutical industry heritage behind it, EVA Pharma has expanded rapidly in recent years, with a CAGR of 24.39 percent over the last three years, propelling…
After several years abroad, Mohamed Eldababy recently returned to his home country to become GSK Egypt’s General Manager. Egypt is an important market for GSK as one of the largest…
See our Cookie Privacy Policy Here
